GFM
RVMD icon

GF Fund Management’s Revolution Medicines RVMD Stock Holding History

GF Fund Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$422K Buy
4,341
+543
+14% +$54.8K 0.01% 231
2025
Q4 		$303K Sell
3,798
-224
-6% -$14.7K 0.01% 254
2025
Q3 		$188K Sell
4,022
-285
-7% -$11.2K ﹤0.01% 297
2025
Q2 		$158K Hold
4,307
– – ﹤0.01% 339
2025
Q1 		$152K Buy
4,307
+775
+22% +$31.5K ﹤0.01% 337
2024
Q4 		$154K Buy
+3,532
New +$178K ﹤0.01% 304

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GF Fund Management's RVMD Position: Q1 2026 in Review

GF Fund Management increased its Revolution Medicines (RVMD) stake by 14% in Q1 2026, buying an estimated $54.8K and bringing the position to 4,341 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #231.

GF Fund Management first reported a position in RVMD in Q4 2024 and has held it in 6 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • GF Fund Management held 4,341 shares of Revolution Medicines worth $422K as of Q1 2026.
  • GF Fund Management bought 543 Revolution Medicines shares in Q1 2026, an estimated $54.8K.
  • Revolution Medicines made up 0.01% of GF Fund Management's portfolio in Q1 2026, its #231 holding.
  • GF Fund Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 6 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.